Viewing Study NCT05168618

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:55 AM
Ignite Modification Date: 2026-05-26 @ 7:45 AM
Study NCT ID: NCT05168618
Status: RECRUITING
Last Update Posted: 2025-05-07
First Post: 2021-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Sponsor: University of Utah
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Castration-Resistant Prostate Carcinoma View
None Metastatic Prostate Adenocarcinoma View
None Stage IV Prostate Cancer AJCC v8 View
None Stage IVA Prostate Cancer AJCC v8 View
None Stage IVB Prostate Cancer AJCC v8 View
Keywords: